Pharmaceutical

Helsinn and Angelini Pharma renew AULIN and MESULID distribution deal

Helsinn Group has renewed an agreement with Angelini Pharma for the commercialisation of AULIN and MESULID.

May 29, 2024 - 04:00
Helsinn and Angelini Pharma renew AULIN and MESULID distribution deal
Helsinn Group has renewed an agreement with Angelini Pharma for the commercialisation of AULIN and MESULID.
Read the original article

Tags:

Previous Article

Asahi Kasei offers to buy Sweden’s Calliditas for $1.04bn

Next Article

QUT team receives US DoD funding for Parkinson’s treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Lantidra wins FDA approval as first-ever type 1 diabetes cell therapy

Lantidra wins FDA approval as first-ever type 1 diabete...

Jun 29, 2023

‘If we don’t, others will’: White House Covid adviser calls on doctors to combat a vacuum of medical information

‘If we don’t, others will’: White House Covid adviser c...

Apr 3, 2023

Formation Bio secures $372m funds for AI-driven drug platform

Formation Bio secures $372m funds for AI-driven drug pl...

Jun 28, 2024